Thank you for your interest in post-marketing study information. The Post-Marketing Study Registration System on this website has ceased updates as of January 1, 2025, and related information is no longer provided on this platform.

For inquiries about post-marketing studies or related research information, we recommend exploring other resources that provide clinical trial information, such as the Taiwan Clinical Trials (TaiwanClinicalTrials.tw), clinical trial centers at major hospitals, or the website of Center for Drug Evaluation (https://www1.cde.org.tw/ct_taiwan/introduction.html).

We appreciate your understanding and continued support!

Company Name	Title of Study	Update Date
Bayer Taiwan Co., Ltd	Systemic treatment patterns of hepatocellular carcinoma (HCC) in Taiwan	2023-08-24
Bayer Taiwan Co., Ltd	Copanlisib in Indolent Non-Hodgkin Lymphoma Patients: A Real-world Taiwan Observation Multicenter Study	2023-08-24
Bayer Taiwan Co., Ltd	Darolutamide Observational Study in non-metastatic castration-resistant prostate cancer patients / DAROL	2023-06-20
GSK	A Phase IV, Prospective, Non-Interventional Cohort Study of Fostemsavir Based Regimen In Heavily Treatment Experienced Patient With Hiv-1 Infection In Taiwan	2023-05-24
AbbVie Biopharmaceuticals GmbH	Prospective Observational Cohort study of patients with moderate to severe chronic plaque psoriasis in Taiwan	2023-03-24
Gilead Sciences Hong Kong Ltd. Taiwan Branch	A Post-Authorization Study to Evaluate Safety and Clinical Outcomes in COVID-19 Patients Treated with Veklury® (Remdesivir) in Taiwan	2023-01-06
Gilead Sciences Hong Kong Limited, Taiwan Branch	Multi-country, non-interventional, cohort study of the effectiveness, safety, adherence, and health-related quality of life in HIV-1 infected adult patients receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Asia.	2023-01-06
Bayer Taiwan Co., Ltd.	Observational study evaluating the physical activity in a subset of damoctocog alfa pegol treated Hemophilia A patients who are enrolled in the HEM-POWR study.	2022-11-29
Bayer Taiwan Co., Ltd.	Observational Study Evaluating Effectiveness and Safety of Real-World Treatment with Damoctocog alfa pegol in Previously Treated Patients with Hemophilia A	2022-07-28
Bayer Taiwan Co., Ltd.	XATOC – Xarelto + Acetylsalicylic Acid: Treatment patterns and Outcomes across the disease Continuum in patients with CAD and/or PAD	2022-07-20